| 01 |  | Vaccine adjuvant | 141256-04-4 | Perform a full‑scope test in accordance with the pharmacopoeia or in‑house control standards, covering physical characteristics, identification, tests, and assay; limit requirements shall be as specified in the standards. |
| 02 |  | darolutamide | 1297538-32-9 | Perform a full‑scope test in accordance with the pharmacopoeia or in‑house control standards, covering physical characteristics, identification, tests, and assay; limit requirements shall be as specified in the standards. |
| 03 |  | Cholesterol (plant-derived) | 57-88-5 | Perform a full‑scope test in accordance with the pharmacopoeia or in‑house control standards, covering physical characteristics, identification, tests, and assay; limit requirements shall be as specified in the standards. |
| 04 |  | Pranlukast | 150821-03-7 | Perform a full‑scope test in accordance with the pharmacopoeia or in‑house control standards, covering physical characteristics, identification, tests, and assay; limit requirements shall be as specified in the standards. |
| 05 |  | Bethanechol | 590-63-6 | Perform a full‑scope test in accordance with the pharmacopoeia or in‑house control standards, covering physical characteristics, identification, tests, and assay; limit requirements shall be as specified in the standards. |
| 06 |  | Tolvaptan sodium phosphate | 942619-88-7 | Perform a full‑scope test in accordance with the pharmacopoeia or in‑house control standards, covering physical characteristics, identification, tests, and assay; limit requirements shall be as specified in the standards. |
| 01 |  | Astaxanthin | 472-61-7 | Perform a full‑scope test in accordance with the pharmacopoeia or in‑house control standards, covering physical characteristics, identification, tests, and assay; limit requirements shall be as specified in the standards. |
| 02 |  | 25-hydroxycholecalciferol | 63283-36-3 | Perform a full‑scope test in accordance with the pharmacopoeia or in‑house control standards, covering physical characteristics, identification, tests, and assay; limit requirements shall be as specified in the standards. |
| 03 |  | Vitamin D3 | 67-97-0 | Perform a full‑scope test in accordance with the pharmacopoeia or in‑house control standards, covering physical characteristics, identification, tests, and assay; limit requirements shall be as specified in the standards. |
| 04 |  | Vitamin K2 (35) | 27670-94-6 | Perform a full‑scope test in accordance with the pharmacopoeia or in‑house control standards, covering physical characteristics, identification, tests, and assay; limit requirements shall be as specified in the standards. |
| 05 |  | Vitamin K2 (20) | 11032-49-8 | Perform a full‑scope test in accordance with the pharmacopoeia or in‑house control standards, covering physical characteristics, identification, tests, and assay; limit requirements shall be as specified in the standards. |
| 06 |  | β-Nicotinamide adenine dinucleotide | 53-84-9 | Perform a full‑scope test in accordance with the pharmacopoeia or in‑house control standards, covering physical characteristics, identification, tests, and assay; limit requirements shall be as specified in the standards. |